Skip to main content

Krueger Christopher W's Form 4 filing

Ventyx Biosciences, Inc. (VTYX) · filed Jun 6, 2023

Accession no.
0001209191-23-034885
Filed
Jun 6, 2023, 7:19 PM ET
Trade date
Jun 5, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $515.4K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krueger Christopher WCIK 0001394208Officer (Chief Business Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 5, 2023Common StockMOption exerciseAcquired+4,716$8.04+$37,916.64281,264Direct
Jun 5, 2023Common StockMOption exerciseAcquired+10,284$0.20+$2,056.8291,548Direct
Jun 5, 2023Common StockSSaleDisposed−12,883$34.31F3−$442,022.17278,665Direct
Jun 5, 2023Common StockSSaleDisposed−2,117$34.65F4−$73,356.59276,548Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 5, 2023Common StockMOption exerciseDisposed−4,716$0.00$0150,460Direct
Jun 5, 2023Common StockMOption exerciseDisposed−10,284$0.00$013,911Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents the weighted average share price of an aggregate total of 12,883 shares sold in the price range of $33.60 to $34.595. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average share price of an aggregate total of 2,117 shares sold in the price range of $34.60 to $34.758. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)